Synthesis and structure–activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitorsChengyan Wang, Ao Zhang, Xing Li et al.|Bioorganic & Medicinal Chemistry Letters|2017Cited by 29
Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone coreMei Han, Meiyu Geng, Yinchun Ji et al.|Bioorganic & Medicinal Chemistry Letters|2016Cited by 6